Disease/Infection News

RSS

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro BioTech announced today that it has been awarded two cash grants totaling approximately $442,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

4 Nov 2010

PolyMedix receives $488,958 grants under QTDP program

PolyMedix, Inc. a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, announced today that it has been awarded two cash grants totaling $488,958 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

4 Nov 2010

Regulus receives $488,989 grant under QTDP program

Regulus Therapeutics Inc. announced today that it has been awarded two grants totaling $488,989 under the Federal government's Qualifying Therapeutic Discovery Project Program.

4 Nov 2010

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Idaho Technology, Inc. (ITI) announced today that it has filed a submission with the U.S. Food and Drug Administration for 510(k) clearance to market its FilmArray Respiratory Panel (RP) as an in vitro diagnostic product for patients with symptoms of upper respiratory tract infection.

4 Nov 2010

Immune Network to complete patient enrollment in Phase 2b imm01 trial for tuberculosis

Immune Network Ltd. a company in the business of discovery and development of immune-based therapies, today announced that patient enrollment will be completed next week for the company's future partner Immunitor's Phase 2b imm01 trial of V5 immunotherapy in 120 patients with tuberculosis.

3 Nov 2010

Strengthening influenza vaccination programs may help states improve coverage against pandemics

Strengthening routine influenza vaccination and health programs may help states improve their vaccination coverage against future pandemics or other health emergencies, a new study suggests.

3 Nov 2010

Scientists recommend research on bacterial vaccine to prevent influenza

Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be important in modern pandemics as well, according to a new article in the Journal of Infectious Diseases co-authored by David M. Morens, M.D., senior advisor to the director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

3 Nov 2010

New global map shows distribution of sickle cell gene

At a global scale, the sickle cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that the gene, whilst potentially deadly, avoids disappearing through natural selection by providing protection against malaria.

3 Nov 2010

CR4354 antibody uses crosslinking mechanism to neutralize West Nile virus

Researchers have learned the structure that results when an antibody binds to the West Nile virus, neutralizing the virus by locking up its infection mechanism. The information could help scientists develop a vaccine against the mosquito-borne disease.

3 Nov 2010

Apps Genius launches Bed Bug Alert app for Apple iPhones

With bedbug infestations on the rise, Apps Genius the developer and publisher of social games and software applications, recently launched the Bed Bug Alert app for the Apple iPhone and iPod Touch. The Bed Bug Alert app is currently available for $1.99 from the Apple Store.

3 Nov 2010

CONRAD receives $5 million award from USAID

CONRAD, leaders in reproductive health and HIV prevention research, today announced a $5 million award from the US Agency for International Development (USAID). The grant will fund research and development of vaginal rings that are contraceptive and also prevent HIV and STI infections.

3 Nov 2010

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, presented results today of preclinical studies that demonstrate its orally-available targeted covalent drug candidate, AVL-192, achieves superior potency against drug-resistant mutations of the Hepatitis C Virus (HCV). These new data were presented today at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) international meeting in Boston, Massachusetts.

3 Nov 2010

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

The U.S. is committed to working "closely together to help meet the challenges facing Cambodia and all of Southeast Asia," Secretary of State Hillary Rodham Clinton pledged Monday during a stop in Cambodia as part of her Asia-Pacific tour, that United Press International reports.

3 Nov 2010

Tests show Haitian cholera strains match ones from South Asia, CDC says

Tests have shown that the strain in Haiti's cholera outbreak is similar to cholera strains found in South Asia, the CDC said on Monday, Agence France-Presse reports (11/1).

3 Nov 2010

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark Diagnostics, Inc. a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States.

3 Nov 2010

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

When the human papillomavirus (HPV) is found in cancer tumours of the tonsil and base of the tongue, patients are more likely to survive following treatment.

3 Nov 2010

Study shows Lactobacillus reuteri bacteria promotes health

There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.

3 Nov 2010

Inviragen receives two grants to develop dengue and chikungunya vaccines

Inviragen, a biotechnology company developing vaccines to protect against infectious diseases worldwide, announced today that it has received two grants totaling $488,958 through the United States government's Qualifying Therapeutic Discovery Project Program.

3 Nov 2010

Combining telaprevir regimen with standard therapy improves SVR rate in hepatitis C

For patients with the most common form of hepatitis C being treated for the first time, the addition of an investigational hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy markedly improved their sustained viral response (SVR or viral cure) rate.

3 Nov 2010

Virus fighting just got a new boost

In a ground breaking study in the UK researchers have identified a previously unknown mechanism that allows the immune system to fight viruses even after they have infected cells. Until now it was believed that antibodies can act only before the virus enters the cells. The team now has found that antibodies that attached themselves to a virus were able to follow it into cells and help to destroy the virus before it started to reproduce. This could open up new avenues of therapy.

2 Nov 2010

Disease/Infection News

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

PolyMedix receives $488,958 grants under QTDP program

Regulus receives $488,989 grant under QTDP program

Idaho seeks FDA marketing clearance for FilmArray Respiratory Panel

Immune Network to complete patient enrollment in Phase 2b imm01 trial for tuberculosis

Strengthening influenza vaccination programs may help states improve coverage against pandemics

Scientists recommend research on bacterial vaccine to prevent influenza

New global map shows distribution of sickle cell gene

CR4354 antibody uses crosslinking mechanism to neutralize West Nile virus

Apps Genius launches Bed Bug Alert app for Apple iPhones

CONRAD receives $5 million award from USAID

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

Tests show Haitian cholera strains match ones from South Asia, CDC says

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

Patients with advanced oropharyngeal cancer caused by HPV have better chances of survival

Study shows Lactobacillus reuteri bacteria promotes health

Inviragen receives two grants to develop dengue and chikungunya vaccines

Combining telaprevir regimen with standard therapy improves SVR rate in hepatitis C

Virus fighting just got a new boost

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News